بدائل البحث:
largest decrease » largest decreases (توسيع البحث), larger decrease (توسيع البحث), marked decrease (توسيع البحث)
i largest » _ largest (توسيع البحث), i large (توسيع البحث)
a large » _ large (توسيع البحث)
b large » _ large (توسيع البحث), i large (توسيع البحث), _ larger (توسيع البحث)
increases » increased (توسيع البحث), increase (توسيع البحث)
largest decrease » largest decreases (توسيع البحث), larger decrease (توسيع البحث), marked decrease (توسيع البحث)
i largest » _ largest (توسيع البحث), i large (توسيع البحث)
a large » _ large (توسيع البحث)
b large » _ large (توسيع البحث), i large (توسيع البحث), _ larger (توسيع البحث)
increases » increased (توسيع البحث), increase (توسيع البحث)
-
81
Table_1_Mutational Profile and Clonal Evolution of Relapsed/Refractory Diffuse Large B-Cell Lymphoma.xlsx
منشور في 2021"…The genes most frequently altered (> 20%) were (in decreasing order of frequency) CDKN2A, PIM1, CD79B, TP53, MYD88, MYC, BTG2, BTG1, CDKN2B, DTX1, CD58, ETV6, and IRF4. …"
-
82
-
83
Supplementary Material for: High-sensitivity Troponin I Measurement in a Large Contemporary Cohort: Implications for Clinical Care
منشور في 2025"…Male sex, higher HDL-C, higher Hgb A1c, decreasing eGFR, and increasing systolic blood pressure were significant predictors of increased hsTnI. …"
-
84
-
85
-
86
-
87
-
88
-
89
-
90
-
91
-
92
DataSheet_1_Mutational Profile and Clonal Evolution of Relapsed/Refractory Diffuse Large B-Cell Lymphoma.xlsx
منشور في 2021"…The genes most frequently altered (> 20%) were (in decreasing order of frequency) CDKN2A, PIM1, CD79B, TP53, MYD88, MYC, BTG2, BTG1, CDKN2B, DTX1, CD58, ETV6, and IRF4. …"
-
93
-
94
-
95
A super-SILAC based proteomics analysis of diffuse large B-cell lymphoma-NOS patient samples to identify new proteins that discriminate GCB and non-GCB lymphomas
منشور في 2019"…<div><p>Diffuse large B-cell lymphoma—not otherwise specified (DLBCL-NOS) is a large and heterogeneous subgroup of non-Hodgkin lymphoma. …"
-
96
-
97
-
98
-
99
-
100
Table 1_Association of dynamic changes in metabolic syndrome components with clinical outcomes in diffuse large B-cell lymphoma.docx
منشور في 2025"…Introduction<p>Diffuse Large B-Cell Lymphoma (DLBCL) is the most common subtype of Non-Hodgkin Lymphoma (NHL), with 20-40% of patients experiencing poor outcomes despite advancements in treatment. …"